Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899140-08-001306
Filing Date
2008-06-10
Accepted
2008-06-10 16:37:38
Documents
2
Period of Report
2008-03-11

Document Format Files

Seq Description Document Type Size
1 oiplp_accp3-060208ex.html 3  
1 oiplp_accp3-060208ex.xml 3 4736
2 EXHIBIT 99.1 EXPLANATION OF RESPONSES o4188614.txt EX-99 1205
  Complete submission text file 0000899140-08-001306.txt   7941
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Issuer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 712 FIFTH AVE 45TH FL NEW YORK NY 10019
ORACLE INSTITUTIONAL PARTNERS L P (Reporting) CIK: 0000924141 (see all company filings)

State of Incorp.: DE
Type: 3 | Act: 34 | File No.: 001-15771 | Film No.: 08891171